Mechanisms of cell cycle arrest by methylseleninic acid

Cancer Research

Volumn 62, Issue 1, 2002, Pages 156-164

  Zhu, Zongjian ^a   Jiang, Weiqin ^a   Thompson, Henry J ^a   Ganther, Howard E ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN E; METHYLSELENINIC ACID; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; SELENIUM DERIVATIVE; SOMATOMEDIN C; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL HYPERPLASIA; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; GROWTH INHIBITION; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EPITHELIAL CELLS; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANOSELENIUM COMPOUNDS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS;

EID: 0036144677     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
2. Selenium inhibition of chemical carcinogenesis
3. Current ideas on selenium as a chemopreventive agent
4. Lessons from basic research in selenium and cancer prevention
5. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial
6. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat
7. In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
8. Characterization of the biological activity of γ-glutamyl-Se-methylselenocysteine: A novel, naturally occurring anticancer agent from garlic
9. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways
10. Activity of Seallylselenocysteine in the presence of methionine γ-lyase on cell growth. DNA integrity, apoptosis, and cell-cycle regulatory molecules
11. Molecular mechanisms associated with Se-allylselenocysteine regulation of cell proliferation and apoptosis
12. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells
13. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gaddgene expression in synchronized mouse mammary epithelial tumor cells
14. Cell cycle and cancer: Critical events at the G1 restriction point
15. Cancer cell cycles
16. Allium chemistry: Synthesis, natural occurrence, biological activity, and chemistry of Se-alk(en)ylselenocysteines and their γ-glutamyl derivatives and oxidation products
17. In vitro effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth. DNA integrity and apoptosis
18. Radiation-induced tumorigenesis in preneoplastic mouse mammary glands in vivo: Significance of p53 status and apoptosis
19. Morphological and functional properties of TM preneoplastic mammary outgrowths
20. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining
21. Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody
22. A novel cyclin encoded by a bc11-linked candidate oncogene
23. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors
24. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1
25. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
26. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast
27. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
28. Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis
29. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
30. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland
31. Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-1 in rats
32. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: Cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity
33. Regulation of neuronal survival by the serine-threonine protein kinase Akt